Shellharbour Private Hospital
| Day | Time |
|---|---|
| Sunday | N/A |
| Monday | 9am – 5pm |
| Tuesday | 9am – 5pm |
| Wednesday | 9am – 5pm |
| Thursday | 9am – 5pm |
| Friday | 9am – 5pm |
| Saturday | N/A |
Consultation Fee
Not specified

Gastroenterologist



Social Profiles:
Colonoscopy
Endoscopy
Treatment for acid reflux
Management of irritable bowel syndrome
Evaluation of abdominal pain
Dr Beshoy Farah is a Gastroenterologist working at Barrack Heights in Shellharbour Specialist Rooms, located at 27 Captain Cook Drive, Barrack Heights NSW 2528. His profile notes that he communicates in English and Arabic and offers a friendly, patient-focused approach. While his exact degree and years of experience aren’t listed, he is described as a specialist in the digestive system and provides care in a local Australian setting. This makes him a good choice for people living near Shellharbour, Barrack Heights, and surrounding areas who need expert gut health support.
Dr Farah’s clinic serves the Barrack Heights area and is easy to reach by local residents. His services include colonoscopy and endoscopy, which are tests that help doctors look inside the gut to find problems. He also treats acid reflux, a common issue that causes heartburn and can affect daily life. For people with irritable bowel syndrome (IBS), he offers management strategies to help reduce symptoms and improve comfort. He can evaluate abdominal pain to understand what is causing it and to guide the right treatment. This range of services is helpful for people who want to stay within their local community for gut health care.
The care style described emphasizes clear communication, patient comfort, and careful listening. Dr Farah aims to explain procedures and results in simple terms so patients feel involved and informed. He supports ongoing learning, which means he keeps up with new methods and guidelines to give up-to-date care. Teamwork is also part of the approach, with collaboration between clinicians, nurses, and admin staff to make visits smooth and supportive.
For local patients, the clinic accepts many payment options including Cash, EFT, EFTPOS, Mastercard, Visa, Tyro, and Eclipse, making it easier to manage costs. Appointments are available at the Shellharbour Specialist Rooms in Barrack Heights, a convenient location for residents of nearby suburbs and towns in New South Wales. Trust in a local gastroenterology expert who speaks both English and Arabic and is dedicated to respectful, professional care. If you need services such as colonoscopy, endoscopy, reflux treatment, IBS management, or abdominal pain evaluation, Dr Farah offers accessible, patient-centered care in the Shellharbour region.
Bachelor of Medicine; Cairo University, Egypt; 2003
Master's in General Medicine; Cairo University, Egypt; 2009
FRACP - Fellow of the Royal Australasian College of Physicians; Royal Australasian College of Physicians, Australia; Post-2011
Fellow of the Royal Australasian College of Physicians (RACP)
Member of the American Society of Gastrointestinal Endoscopy (ASGE)
Member of the American College of Gastroenterology (ACG)
Member of the Gastroenterological Society of Australia (GESA)
Current: Staff Specialist Gastroenterologist and Hepatologist at Shoalhaven District Memorial Hospital (Nowra, NSW); Visiting Medical Officer (VMO) at St George Hospital, Sydney; VMO/affiliated roles at Shellharbour Private Hospital, Nowra Private Hospital, Campbelltown Private Hospital, and Wollongong Day Surgery; Private practice consultations in Barrack Heights, Shellharbour, and Gledswood Hills.
2011–present: Relocated to Australia; advanced training in Gastroenterology at St George Hospital, Sydney.
Pre-2011: Specialist training in Gastroenterology, Hepatology, and Liver Transplant at a busy advanced centre in Egypt.
Extensive work on colonic polyps, viral hepatitis, liver disease; sub-investigator in trials for HCV treatments and hepatocellular carcinoma.
Description:Background - Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, including Australia. The absence of a consensus clinical practice guideline (CPG) specific to HCC management poses challenges in reducing morbidity, mortality, and improving patient recovery. This systematic review aims to evaluate the existing evidence and assess the potential of published guidelines, including those with an international scope, to provide guidance for healthcare professionals in Australia. Methods - Electronic search of MEDLINE, Embase, Cochrane Library, Google Scholar, and PubMed was conducted. Peer-reviewed English language articles from 2005 to June 2022 were included if they described management of HCC as part of an evidence-based overall management plan or CPG. The quality of the included CPGs was assessed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Results - Twenty-one articles from 16 regions throughout the world were included in this review. All included guidelines (n = 21, 100%) recommended evaluating cirrhosis, hepatitis B, and hepatitis C as potential risk factors of HCC. Obesity and non-alcoholic fatty liver disease were recommended by 19 CPGs (91%) as risk factor for HCC. Fourteen guidelines (67%) endorsed using the BCLC staging system. Eighteen guidelines (86%) recommended a multidisciplinary approach for the management of HCC. Eighteen guidelines (86%) advised that surveillance using ultrasound should be implemented in all cirrhotic patients every 6 months regardless of the cause of cirrhosis. AGREE II mean overall assessment score was 90% indicating that all guidelines included were highly recommended in majority of domains. Conclusions - The included CPGs provided a comprehensive approach, emphasizing the evaluation of risk factors, utilization of the BCLC staging system, and the importance of a multidisciplinary approach. Regular surveillance using ultrasound for cirrhotic patients was widely recommended. An understanding of contemporary international CPGs can prioritize aspects of the management of HCC to assist healthcare professionals to develop a national guideline to enable standardized, comprehensive, and evidence-based care for patients with HCC.
